DE69434117D1 - Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien - Google Patents

Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien

Info

Publication number
DE69434117D1
DE69434117D1 DE69434117T DE69434117T DE69434117D1 DE 69434117 D1 DE69434117 D1 DE 69434117D1 DE 69434117 T DE69434117 T DE 69434117T DE 69434117 T DE69434117 T DE 69434117T DE 69434117 D1 DE69434117 D1 DE 69434117D1
Authority
DE
Germany
Prior art keywords
typing
hepatitis
viruses
reagents
used therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69434117T
Other languages
English (en)
Other versions
DE69434117T2 (de
DE69434117T3 (de
Inventor
Y Chien
George Kuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22029220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69434117(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of DE69434117D1 publication Critical patent/DE69434117D1/de
Publication of DE69434117T2 publication Critical patent/DE69434117T2/de
Application granted granted Critical
Publication of DE69434117T3 publication Critical patent/DE69434117T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69434117T 1993-05-10 1994-05-09 Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien Expired - Lifetime DE69434117T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6040093A 1993-05-10 1993-05-10
US60400 1993-05-10
PCT/US1994/005151 WO1994027153A1 (en) 1993-05-10 1994-05-09 Methods of typing hepatitis c virus and reagents for use therein

Publications (3)

Publication Number Publication Date
DE69434117D1 true DE69434117D1 (de) 2005-01-20
DE69434117T2 DE69434117T2 (de) 2006-02-02
DE69434117T3 DE69434117T3 (de) 2009-10-08

Family

ID=22029220

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69434117T Expired - Lifetime DE69434117T3 (de) 1993-05-10 1994-05-09 Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien

Country Status (19)

Country Link
US (3) US6054264A (de)
EP (1) EP0698216B2 (de)
JP (1) JP3645904B2 (de)
KR (1) KR100330278B1 (de)
CN (1) CN1129795C (de)
AT (1) ATE281647T1 (de)
CZ (1) CZ294629B6 (de)
DE (1) DE69434117T3 (de)
DK (1) DK0698216T4 (de)
ES (1) ES2232815T5 (de)
GE (1) GEP20012421B (de)
HU (1) HU224513B1 (de)
PL (3) PL175338B1 (de)
PT (1) PT698216E (de)
RO (1) RO115471B1 (de)
RU (1) RU2158928C2 (de)
SK (1) SK282543B6 (de)
UA (1) UA46707C2 (de)
WO (1) WO1994027153A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0610436B9 (de) 1991-11-21 2003-03-26 Common Services Agency Detektion des Hepatis-C Virus.
BR9405334A (pt) 1993-04-27 1999-05-25 Innogenetics Nv Novas sequências de genótipos de vírus da hepatite c e seu uso como agentes terapêuticos e diagnóstico
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
PL175338B1 (pl) * 1993-05-10 1998-12-31 Chiron Corp Polipeptyd i reagent do klasyfikowania jednego lub większej liczby typów wirusa zapalenia wątroby typu C (HCV)
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
DE19504302A1 (de) * 1995-02-09 1996-08-14 Boehringer Mannheim Gmbh Methode zur serologischen Typisierung mittels typspezifischer Antigene
WO1996034013A1 (fr) * 1995-04-28 1996-10-31 Srl, Inc. Compose peptidique antigenique et methode de dosage immunologique
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
US7052830B1 (en) * 1998-06-09 2006-05-30 Branch Andrea D Hepatitis C virus peptides and uses thereof
CA2354152A1 (en) * 1998-11-20 2000-06-02 Bio Merieux Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications
US6995299B2 (en) * 1999-11-02 2006-02-07 University Of Connecticut Propagation of human hepatocytes in non-human animals
US8124348B2 (en) * 2000-08-23 2012-02-28 Jonathan Zmuda Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes
AU2002311897A1 (en) * 2001-05-09 2002-11-18 Third Wave Technologies, Inc. Nucleic acid detection in pooled samples
US7196183B2 (en) * 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US20030215917A1 (en) * 2002-04-04 2003-11-20 Mingjun Huang Assay for evaluation of activity of compounds against HCV using a novel detection system in the HCV replicon
US20050202036A1 (en) * 2003-07-22 2005-09-15 Branch Andrea D. Alternate reading frame polypeptides drived from hepatitis C and methods of their use
AU2004258750A1 (en) * 2003-07-25 2005-02-03 Centre National De La Recherche Scientifique -Cnrs Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis C
US8124747B2 (en) * 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
US7473773B2 (en) 2004-01-07 2009-01-06 Third Wave Technologies, Inc. Determination of hepatitis C virus genotype
JP4533656B2 (ja) * 2004-04-28 2010-09-01 アボットジャパン株式会社 特異性の改良されたｃ型肝炎ウイルス（ｈｃｖ）抗体測定法
US7858752B2 (en) 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868105A (en) * 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
CN1049686C (zh) * 1987-11-18 2000-02-23 希龙股份有限公司 非ａ和非ｂ肝炎病毒的诊断及疫苗
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
RU2130969C1 (ru) * 1990-04-04 1999-05-27 Чирон Корпорейшн Композиция для диагностики гепатита c человека (варианты), способ и набор для обнаружения антител к вирусу гепатита c человека
US6190864B1 (en) * 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
RO117329B1 (ro) * 1991-06-24 2002-01-30 Chiron Corp Emeryville Polipeptide care contin o secventa a virusului hepatitei c
DK0529493T3 (da) * 1991-08-27 1998-08-24 Hoffmann La Roche Fremgangsmåder og reagenser til hepatitis C-detektion
EP0532258A2 (de) * 1991-09-09 1993-03-17 Immuno Japan Inc. Oligonukleotide und Verfahren zum Nachweis von HCV-Gentypen
AU2679492A (en) * 1991-09-16 1993-04-27 Abbott Laboratories Hepatitis c assay
EP0610436B9 (de) * 1991-11-21 2003-03-26 Common Services Agency Detektion des Hepatis-C Virus.
CN1053196C (zh) 1992-07-16 2000-06-07 株式会社先端生命科学研究所 用于丙型肝炎病毒分类的抗原肽, 含有所述肽的药盒及用所述肽进行分类的方法
HUT73150A (en) * 1992-11-06 1996-06-28 Chiron Mimotopes Pty Ltd Modular polymer and support for the synthesis thereof
JP3751315B2 (ja) 1993-05-05 2006-03-01 コモン サーヴィシス エージェンシー Ｃ型肝炎ウイルス４、５及び６型
PL175338B1 (pl) * 1993-05-10 1998-12-31 Chiron Corp Polipeptyd i reagent do klasyfikowania jednego lub większej liczby typów wirusa zapalenia wątroby typu C (HCV)
EP0729973A4 (de) * 1993-10-29 1998-12-30 Srl Inc Eine antigene peptidverbindung und ein immunoassay-verfahren

Also Published As

Publication number Publication date
ES2232815T3 (es) 2005-06-01
HU224513B1 (hu) 2005-10-28
SK135995A3 (en) 1996-09-04
US6416944B1 (en) 2002-07-09
EP0698216A1 (de) 1996-02-28
KR100330278B1 (ko) 2002-08-19
US6054264A (en) 2000-04-25
PL175338B1 (pl) 1998-12-31
HUT73384A (en) 1996-07-29
HU9503219D0 (en) 1996-01-29
WO1994027153A1 (en) 1994-11-24
US6416946B1 (en) 2002-07-09
UA46707C2 (uk) 2002-06-17
EP0698216B2 (de) 2009-02-25
PL175342B1 (pl) 1998-12-31
RU2158928C2 (ru) 2000-11-10
EP0698216B1 (de) 2004-11-03
PT698216E (pt) 2005-03-31
DE69434117T2 (de) 2006-02-02
CN1129795C (zh) 2003-12-03
DE69434117T3 (de) 2009-10-08
SK282543B6 (sk) 2002-10-08
PL175360B1 (pl) 1998-12-31
JP3645904B2 (ja) 2005-05-11
PL311653A1 (en) 1996-03-04
CZ294629B6 (cs) 2005-02-16
ATE281647T1 (de) 2004-11-15
CZ292995A3 (en) 1996-05-15
GEP20012421B (en) 2001-04-25
CN1125982A (zh) 1996-07-03
ES2232815T5 (es) 2009-06-15
RO115471B1 (ro) 2000-02-28
JPH08510329A (ja) 1996-10-29
DK0698216T3 (da) 2005-02-14
DK0698216T4 (da) 2009-06-15

Similar Documents

Publication Publication Date Title
DE69434117D1 (de) Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
ATE179459T1 (de) Verfahren zur typisierung von hcv-isolaten
DE68915202T2 (de) Verfahren zur Vermehrung und zum Nachweis von Nukleinsäuresequenzen.
DE68907407T2 (de) Verfahren zur sequenzanalyse von dna.
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
DE69329108T2 (de) Verfahren zur inaktivierung von viren
ATE551423T1 (de) Sequenzen von hepatitis c virus-genotypen sowie ihre verwendungen als therapeutika und diagnostika
IT1278077B1 (it) Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal
DE68916588T2 (de) Verfahren und Gerät zur Feststellung von Gasen.
DK0489968T3 (da) Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
DE69432043T2 (de) Diagnostische Reagenzien zum Nachweis von Antikörper gegen EBV
ATE191792T1 (de) Verfahren zur detektion von hepatitis c
DE69006489D1 (de) Verfahren zur kontinuierlichen wiedergewinnung von fluorwasserstoffgas.
ATE270345T1 (de) Nukleinsaeure erkennung von hepatitis gb virus
DE69106141D1 (de) Non-a non-b sequenzen.
FI952778A0 (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
DE69111637D1 (de) Verfahren zur Trennung und Konzentration von Phosphopeptiden.
ATE91156T1 (de) Verfahren zur sequenzanalyse von dna.
DE3674802D1 (de) Verfahren zum nachweis von proteinen und viren.
DE406296T1 (de) Verfahren zur sequenzanalyse von dna.
ATE62019T1 (de) Verfahren zur herstellung von hcmvglykoproteinen, antikoerper dagegen und hcmvvakzine und dazu zu verwendende rekombinante vektoren.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS,INC.(N.D.GES, US